Related Experiment Videos

Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy

Sufi M Thomas1, Qing Zeng, Kevin F Dyer

  • 1Department of Otolaryngology, University of Pittsburgh and the University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.

Cancer Gene Therapy
|July 2, 2003
PubMed

Insights

Detecting liposomal gene therapy DNA in distant organs depends on assay sensitivity. Highly sensitive PCR detected exogenous DNA widely, while less sensitive methods showed limited distribution, highlighting assay importance in gene therapy research.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Liposome-mediated gene transfer is common in cancer therapy, but DNA tissue distribution after local administration is poorly understood.
  • Previous work established EGFR antisense gene therapy efficacy in head and neck squamous cell carcinoma (HNSCC) xenografts with no systemic toxicity.
  • Intramuscular or intratumoral administration of liposomal-DNA complexes requires clear understanding of biodistribution.

Purpose of the Study:

  • To compare different methods for detecting exogenous DNA in plasma and tissues after intramuscular injection of EGFR antisense gene therapy.
  • To assess the sensitivity and reliability of PCR and optical imaging for tracking gene therapy DNA distribution.
  • To investigate the potential integration of foreign DNA into the host genome.

Main Methods:

  • Comparison of PCR using genomic DNA plus plasmid DNA versus PCR using total RNA plus plasmid DNA for sensitivity.
  • Optical imaging to visualize plasmid DNA distribution.
  • Southern blot hybridization to assess DNA integration into the host genome.

Main Results:

  • Highly sensitive PCR (detecting <500 DNA molecules) revealed exogenous DNA in all organs up to 1 month post-injection.
  • Less sensitive PCR (RNA template) detected DNA only at the injection site within 1 week.
  • Optical imaging showed DNA exclusively at the injection site; Southern blot found no evidence of DNA integration.

Conclusions:

  • The detection of intralesionally administered liposomal gene therapy in distant organs is directly correlated with the sensitivity of the detection method.
  • Assay selection is critical for accurately determining the biodistribution and persistence of gene therapy agents.
  • Exogenous DNA was widely distributed but did not integrate into the host genome in this model.

Related Concept Videos